Roble Belko & Company Inc raised its position in iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Free Report) by 917.6% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 72,379 shares of the company’s stock after purchasing an additional 65,266 shares during the period. Roble Belko & Company Inc’s holdings in iShares iBonds Dec 2032 Term Corporate ETF were worth $1,829,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the company. Cary Street Partners Financial LLC raised its stake in shares of iShares iBonds Dec 2032 Term Corporate ETF by 2.8% during the 4th quarter. Cary Street Partners Financial LLC now owns 14,221 shares of the company’s stock worth $363,000 after buying an additional 392 shares during the last quarter. IFP Advisors Inc boosted its position in shares of iShares iBonds Dec 2032 Term Corporate ETF by 2.8% in the 3rd quarter. IFP Advisors Inc now owns 33,176 shares of the company’s stock worth $850,000 after buying an additional 888 shares in the last quarter. Newman Dignan & Sheerar Inc. grew its stake in iShares iBonds Dec 2032 Term Corporate ETF by 11.6% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 9,449 shares of the company’s stock valued at $241,000 after acquiring an additional 985 shares during the last quarter. Farmers National Bank grew its stake in iShares iBonds Dec 2032 Term Corporate ETF by 3.4% in the 4th quarter. Farmers National Bank now owns 31,981 shares of the company’s stock valued at $816,000 after acquiring an additional 1,040 shares during the last quarter. Finally, Gradient Capital Advisors LLC grew its stake in iShares iBonds Dec 2032 Term Corporate ETF by 3.6% in the 4th quarter. Gradient Capital Advisors LLC now owns 33,824 shares of the company’s stock valued at $864,000 after acquiring an additional 1,187 shares during the last quarter.
iShares iBonds Dec 2032 Term Corporate ETF Stock Performance
NYSEARCA:IBDX opened at $25.09 on Monday. The firm has a 50-day moving average price of $25.19 and a two-hundred day moving average price of $25.39. iShares iBonds Dec 2032 Term Corporate ETF has a twelve month low of $24.88 and a twelve month high of $26.77.
iShares iBonds Dec 2032 Term Corporate ETF Profile
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index of USD-denominated, investment grade corporate bonds maturing between January 1, 2032 and December 15, 2032. IBDX was launched on Jun 28, 2022 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares iBonds Dec 2032 Term Corporate ETF
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding IBDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Free Report).
Receive News & Ratings for iShares iBonds Dec 2032 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2032 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
